Connected Drug Delivery Devices Market Forecast 2023-2028 | Size US$ 3,517.0 Million & Growth Rate 33.6% CAGR

IMARC Group, a leading market research company, has recently released a report titled "𝐂𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐡𝐚𝐫𝐞, 𝐒𝐢𝐳𝐞, 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟑-𝟐𝟎𝟐𝟖." The study provides a detailed analysis of the industry, including the global connected drug delivery devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

𝙍𝙚𝙥𝙤𝙧𝙩 𝙃𝙞𝙜𝙝𝙡𝙞𝙜𝙝𝙩𝙨

𝐇𝐨𝐰 𝐁𝐢𝐠 𝐢𝐬 𝐭𝐡𝐞 𝐂𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?

Global connected drug delivery devices market size reached US$ 652.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,517.0 Million by 2028, exhibiting a growth rate (CAGR) of 33.6% during 2023-2028.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐚 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.imarcgroup.com/connected-drug-delivery-devices-market/requestsample

What is Connected Drug Delivery Devices?

Connected drug delivery devices refer to smart wireless electronic systems that support patient supervision and counselling in home settings. They are equipped with dose reminders, adherence trackers, sensors, and monitoring tools to provide instant feedback and education tools for personalized sufferer care. Connected drug delivery devices are convenient and save costs associated with clinic-based treatment. Consequently, they are widely utilized in the remote monitoring of patients with asthma, diabetes, hepatitis C, hypertension, tuberculosis, clinically isolated syndrome, multiple sclerosis, chronic obstructive pulmonary disease (COPD), and liver and renal transplant recipients.

What are the Growth Prospects and Trends in the Connected Drug Delivery Devices Industry?

The increasing expenditure on medical management and the rising need to improve patient treatment outcomes are primarily augmenting the connected drug delivery devices market. Furthermore, the shifting preferences of consumers toward home-based supervision are positively influencing the global market. Apart from this, the inflating number of individuals suffering from chronic diseases and the growing focus on preventive care are acting as significant growth-inducing factors. Moreover, the widespread adoption of these devices in hospitals and laboratories for maintaining electronic health records (EHR) is also bolstering the market growth. Besides this, numerous manufacturers are offering devices that can connect to apps and programs, allow data transfer, enable automated tracking, and maximize sufferer safety, which is further catalyzing the global market. Additionally, the escalating demand for these devices in biopharma companies, as they provide access to real-time patient data for determining adherence improvement outcomes to regulators, payers, and sufferers, is expected to drive the connected drug delivery devices market in the coming years.

𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰: https://www.imarcgroup.com/checkout?id=3738&method=1

Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.

Who are the Key Players Operating in the Connected Drug Delivery Devices Market?

The competitive landscape of the industry has also been examined along with the profiles of the key players.

• Adherium Ltd.
• BioCorp Production
• Cohero Health Inc. (AptarGroup Inc.)
• Elcam Medical ACS. Ltd
• Findair Sp. z o. o.
• Merck KGaA
• Phillips Medisize (Molex LLC)
• Propeller Health (Resmed Inc.)
• Teva Pharmaceutical Industries Ltd.
• West Pharmaceutical Services Inc.

What is Included in Market Segmentation?

The report has categorized the market based on product, end user, technology and region.

Breakup by Product:
• Connected Sensors
o Connected Inhaler Sensors
o Connectable Injection Sensors
• Integrated Connected Devices
o Connected Inhalation Devices
o Connected Injection Devices

Based on End User:
• Hospitals and Healthcare Providers
• Homecare

Analysed by Technology:
• Bluetooth
• NFC
• Others

Regional Insights:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

𝐀𝐬𝐤 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐟𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐟𝐮𝐥𝐥 𝐫𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐓𝐎𝐂 & 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐅𝐢𝐠𝐮𝐫𝐞𝐬: https://www.imarcgroup.com/request?type=report&id=3738&flag=C

Key Highlights of the Report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.